Nayara secures SFC-led pre-seed funding for patient support AI
The UK healthtech company will develop its platform, pursue clinical validation and grow commercial operations.
Nayara has closed a pre-seed round led by SFC Capital to expand its AI patient-support platform. The funding will support product development, clinical validation and commercial growth.
The company builds companions for hospitals, healthcare systems and medical technology businesses. Patients can receive guidance between appointments, while care teams receive information about concerns requiring their attention.
Its platform handles routine communication and check-ins and has supported hundreds of patients in breast cancer care. Nayara aims to give clinical teams more visibility into patients’ progress outside appointments.
Use of funds
Product development
Clinical validation
Commercial expansion